American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Nephrology PRN Focus Session — Tri-Fecta Triumph: Clinical Management of Cardiovascular, Kidney, and Metabolic (CKM) Syndrome

Saturday, October 12, 2024 from 3:30 PM to 5:00 PM MST at Convention Center North Building / North Ballroom 120A

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-132-L01-P
Activity Type: A Knowledge-Based Activity

In this clinical session, experts will provide a thorough exploration of the ever-evolving landscape in managing the intricate interplay among cardiovascular (CV) health, kidney function, and metabolic factors. Coined as Cardiovascular-Kidney-Metabolic (CKM) Syndrome, this phenomenon has emerged as a pivotal nexus where obesity, diabetes, chronic kidney disease (CKD), and CV issues intersect. A significant development in the field is the updated 2023 Clinical Practice Guideline for the Evaluation and Management of CKD by KDIGO, building upon the foundation laid in 2012. The session will not only examine these forthcoming renal guidelines but will also dissect the unique challenges faced by individuals with established CV disease and concurrent metabolic risk factors or CKD. This exploration will shed light on nuanced management considerations, emphasizing the importance of staying abreast of the latest developments. Despite the wealth of existing literature supporting current scientific understanding and approaches to the prevention and management of CKM syndrome, critical knowledge gaps persist. This presentation will confront key limitations in the available data that underpins clinical care for CKM syndrome. Topics to be addressed include early-life prevention, effective screening for risk factors, interdisciplinary care models, optimal strategies for lifestyle modification and weight loss, as well as targeting emerging cardioprotective and kidney-protective therapies. Furthermore, the session will delve into the challenges of managing patients with both cardiovascular disease and chronic kidney disease, providing valuable insights into the impact of systematically assessing and addressing social determinants of health.

Learning Objectives

1. Summarize the latest developments and guidelines in the management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome.

2. Discuss the complex interplay between metabolic risk factors, chronic kidney disease (CKD), and the cardiovascular system.

3. Assess goals of therapy and efficacy for the management of CKM.

4. Outline emerging therapeutic interventions that demonstrate significant benefits in reducing morbidity and mortality within the CKM Syndrome patient cohort.

5. Identify interdisciplinary care models that consider the bidirectional associations between cardiac, metabolic and renal dysfunction, addressing the multifaceted aspects of CKM health.

6. Review the potential benefits and risks associated with new therapeutic approaches in the context of CKM disorders.

Lavinia Salama, Pharm.D., BCACP, BC-ADM, CDCES
Moderator:Lavinia Salama, Pharm.D., BCACP, BC-ADM, CDCES
  View Biography

Unveiling the Tapestry of CKM Syndrome: Insights, Guidelines, and Challenges

3:30 PM
Calvin J. Meaney, Pharm.D., FCCP, BCPS
Speaker:Calvin J. Meaney, Pharm.D., FCCP, BCPS

Clinical Associate Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
Buffalo, New York

  View Biography

Bridging Knowledge to Action: Practical Strategies for Optimal CKM Syndrome Care

4:05 PM to 5:00 PM
Michelle A. Fravel, Pharm.D., FCCP, BCPS
Speaker:Michelle A. Fravel, Pharm.D., FCCP, BCPS

Clinical Professor
University of Iowa College of Pharmacy
Iowa City, Iowa

  View Biography

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.